{"entity":{"type":"insider","cik":"0001776412","url":"/insider/0001776412","json_url":"/insider/0001776412.json","name":"Schroeder Thilo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":135,"n_filings":37,"first":"2020-12-08","last":"2024-12-09","span_basis":"filed_date"},"name_variants":[{"name":"Schroeder Thilo","source":"filing","n_filings":37,"first_seen":"2020-12-08","last_seen":"2024-12-09"}],"transactions":[{"id":2757400,"accession":"0001415889-24-028638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028638","line_url":"/filing/0001415889-24-028638","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1304347.0,"shares_display":"1,304,347","price_per_share":46.0,"price_display":"46.00","price_state":"stated","total_value":59999962.0,"total_display":"59,999,962.00","total_whole":"59,999,962","shares_owned_after":760869.0,"shares_owned_after_display":"760,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider","n_lines":2},{"id":8702213,"accession":"0001209191-23-017977","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-017977","line_url":"/filing/0001209191-23-017977","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":20.45604,"price_display":"20.46","price_state":"stated","total_value":2045604.0,"total_display":"2,045,604.00","total_whole":"2,045,604","shares_owned_after":1546934.0,"shares_owned_after_display":"1,546,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-10","scope":"insider","n_lines":2},{"id":8702208,"accession":"0001209191-23-017977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-017977","line_url":"/filing/0001209191-23-017977","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":12100000.0,"total_display":"12,100,000.00","total_whole":"12,100,000","shares_owned_after":618181.0,"shares_owned_after_display":"618,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-10","scope":"insider","n_lines":2},{"id":6986640,"accession":"0001209191-22-043221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043221","line_url":"/filing/0001209191-22-043221#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1221315.0,"shares_owned_after_display":"1,221,315","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-26","scope":"insider"},{"id":6984985,"accession":"0001209191-22-021518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-021518","line_url":"/filing/0001209191-22-021518#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":725.0,"shares_display":"725","price_per_share":24.71,"price_display":"24.71","price_state":"stated","total_value":17914.75,"total_display":"17,914.75","total_whole":"17,915","shares_owned_after":971315.0,"shares_owned_after_display":"971,315","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-28","filed_date":"2022-03-29","scope":"insider"},{"id":6984983,"accession":"0001209191-22-021518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-021518","line_url":"/filing/0001209191-22-021518","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42000.0,"shares_display":"42,000","price_per_share":24.793632142857142,"price_display":"24.79","price_state":"stated","total_value":1041332.55,"total_display":"1,041,332.55","total_whole":"1,041,333","shares_owned_after":957825.0,"shares_owned_after_display":"957,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-29","scope":"insider","n_lines":2},{"id":6846301,"accession":"0001209191-22-020984","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-020984","line_url":"/filing/0001209191-22-020984#line-6","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49119.0,"shares_display":"49,119","price_per_share":24.26,"price_display":"24.26","price_state":"stated","total_value":1191626.94,"total_display":"1,191,626.94","total_whole":"1,191,627","shares_owned_after":928590.0,"shares_owned_after_display":"928,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-03-24","scope":"insider"},{"id":6846298,"accession":"0001209191-22-020984","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-020984","line_url":"/filing/0001209191-22-020984","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53118.0,"shares_display":"53,118","price_per_share":23.720241349448397,"price_display":"23.72","price_state":"stated","total_value":1259971.78,"total_display":"1,259,971.78","total_whole":"1,259,972","shares_owned_after":864061.0,"shares_owned_after_display":"864,061","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-24","scope":"insider","n_lines":2},{"id":6846291,"accession":"0001209191-22-020984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-020984","line_url":"/filing/0001209191-22-020984","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130127.0,"shares_display":"130,127","price_per_share":23.346624220953377,"price_display":"23.35","price_state":"stated","total_value":3038026.17,"total_display":"3,038,026.17","total_whole":"3,038,026","shares_owned_after":772852.0,"shares_owned_after_display":"772,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-22","filed_date":"2022-03-24","scope":"insider","n_lines":3},{"id":6147473,"accession":"0001209191-22-020453","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-020453","line_url":"/filing/0001209191-22-020453","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75731.0,"shares_display":"75,731","price_per_share":20.73568736712839,"price_display":"20.74","price_state":"stated","total_value":1570334.34,"total_display":"1,570,334.34","total_whole":"1,570,334","shares_owned_after":695347.0,"shares_owned_after_display":"695,347","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-21","scope":"insider","n_lines":2},{"id":6147466,"accession":"0001209191-22-020453","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-020453","line_url":"/filing/0001209191-22-020453","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":82200.0,"shares_display":"82,200","price_per_share":20.29981508515815,"price_display":"20.30","price_state":"stated","total_value":1668644.8,"total_display":"1,668,644.80","total_whole":"1,668,645","shares_owned_after":620495.0,"shares_owned_after_display":"620,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-21","scope":"insider","n_lines":2},{"id":6147460,"accession":"0001209191-22-020453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020453","line_url":"/filing/0001209191-22-020453#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10120.0,"shares_display":"10,120","price_per_share":18.78,"price_display":"18.78","price_state":"stated","total_value":190053.6,"total_display":"190,053.60","total_whole":"190,054","shares_owned_after":538295.0,"shares_owned_after_display":"538,295","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider"},{"id":6424887,"accession":"0001209191-22-018591","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-018591","line_url":"/filing/0001209191-22-018591#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3110.0,"shares_display":"3,110","price_per_share":20.93,"price_display":"20.93","price_state":"stated","total_value":65092.3,"total_display":"65,092.30","total_whole":"65,092","shares_owned_after":528175.0,"shares_owned_after_display":"528,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":6424884,"accession":"0001209191-22-018591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-018591","line_url":"/filing/0001209191-22-018591","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40400.0,"shares_display":"40,400","price_per_share":20.61066188118812,"price_display":"20.61","price_state":"stated","total_value":832670.74,"total_display":"832,670.74","total_whole":"832,671","shares_owned_after":522576.0,"shares_owned_after_display":"522,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-14","scope":"insider","n_lines":2},{"id":6243968,"accession":"0001209191-22-017739","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-017739","line_url":"/filing/0001209191-22-017739#line-6","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39600.0,"shares_display":"39,600","price_per_share":20.07,"price_display":"20.07","price_state":"stated","total_value":794772.0,"total_display":"794,772.00","total_whole":"794,772","shares_owned_after":484665.0,"shares_owned_after_display":"484,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-09","scope":"insider"},{"id":6243966,"accession":"0001209191-22-017739","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-017739","line_url":"/filing/0001209191-22-017739","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103833.0,"shares_display":"103,833","price_per_share":18.991821675189968,"price_display":"18.99","price_state":"stated","total_value":1971977.82,"total_display":"1,971,977.82","total_whole":"1,971,978","shares_owned_after":384114.0,"shares_owned_after_display":"384,114","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-09","scope":"insider","n_lines":3},{"id":6243956,"accession":"0001209191-22-017739","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017739","line_url":"/filing/0001209191-22-017739","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103005.0,"shares_display":"103,005","price_per_share":18.38848589874278,"price_display":"18.39","price_state":"stated","total_value":1894105.99,"total_display":"1,894,105.99","total_whole":"1,894,106","shares_owned_after":334153.0,"shares_owned_after_display":"334,153","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider","n_lines":2},{"id":6813173,"accession":"0001209191-22-016484","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-016484","line_url":"/filing/0001209191-22-016484#line-8","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56300.0,"shares_display":"56,300","price_per_share":17.69,"price_display":"17.69","price_state":"stated","total_value":995947.0,"total_display":"995,947.00","total_whole":"995,947","shares_owned_after":238227.0,"shares_owned_after_display":"238,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-04","scope":"insider"},{"id":6813166,"accession":"0001209191-22-016484","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-016484","line_url":"/filing/0001209191-22-016484","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65637.0,"shares_display":"65,637","price_per_share":18.537613998202232,"price_display":"18.54","price_state":"stated","total_value":1216753.37,"total_display":"1,216,753.37","total_whole":"1,216,753","shares_owned_after":171054.0,"shares_owned_after_display":"171,054","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider","n_lines":2},{"id":6813157,"accession":"0001209191-22-016484","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-016484","line_url":"/filing/0001209191-22-016484#line-5","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":116290.0,"shares_display":"116,290","price_per_share":18.94,"price_display":"18.94","price_state":"stated","total_value":2202532.6,"total_display":"2,202,532.60","total_whole":"2,202,533","shares_owned_after":116290.0,"shares_owned_after_display":"116,290","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4236938,"accession":"0001209191-21-060100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060100","line_url":"/filing/0001209191-21-060100#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":30.15,"price_display":"30.15","price_state":"stated","total_value":24120.0,"total_display":"24,120.00","total_whole":"24,120","shares_owned_after":1101283.0,"shares_owned_after_display":"1,101,283","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-08","scope":"insider"},{"id":4143319,"accession":"0001209191-21-059163","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-059163","line_url":"/filing/0001209191-21-059163#line-3","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":30.08,"price_display":"30.08","price_state":"stated","total_value":3008.0,"total_display":"3,008.00","total_whole":"3,008","shares_owned_after":1102083.0,"shares_owned_after_display":"1,102,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-04","scope":"insider"},{"id":4143314,"accession":"0001209191-21-059163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059163","line_url":"/filing/0001209191-21-059163#line-2","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11541.0,"shares_display":"11,541","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":347384.1,"total_display":"347,384.10","total_whole":"347,384","shares_owned_after":1102183.0,"shares_owned_after_display":"1,102,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-04","scope":"insider"},{"id":4143310,"accession":"0001209191-21-059163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059163","line_url":"/filing/0001209191-21-059163#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2978.0,"shares_display":"2,978","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":89429.34,"total_display":"89,429.34","total_whole":"89,429","shares_owned_after":1113724.0,"shares_owned_after_display":"1,113,724","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-10-04","scope":"insider"},{"id":4540128,"accession":"0001209191-21-058091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058091","line_url":"/filing/0001209191-21-058091#line-2","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5708.0,"shares_display":"5,708","price_per_share":30.04,"price_display":"30.04","price_state":"stated","total_value":171468.32,"total_display":"171,468.32","total_whole":"171,468","shares_owned_after":1116702.0,"shares_owned_after_display":"1,116,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-09-29","scope":"insider"},{"id":4540126,"accession":"0001209191-21-058091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-058091","line_url":"/filing/0001209191-21-058091#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1753.0,"shares_display":"1,753","price_per_share":30.11,"price_display":"30.11","price_state":"stated","total_value":52782.83,"total_display":"52,782.83","total_whole":"52,783","shares_owned_after":1122410.0,"shares_owned_after_display":"1,122,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-29","scope":"insider"},{"id":5405858,"accession":"0001209191-21-057711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057711","line_url":"/filing/0001209191-21-057711#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":1124163.0,"shares_owned_after_display":"1,124,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-24","scope":"insider"},{"id":5500015,"accession":"0001209191-21-057099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057099","line_url":"/filing/0001209191-21-057099#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":711.0,"shares_display":"711","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":21351.33,"total_display":"21,351.33","total_whole":"21,351","shares_owned_after":1124263.0,"shares_owned_after_display":"1,124,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":4586953,"accession":"0001209191-21-055782","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-055782","line_url":"/filing/0001209191-21-055782#line-4","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13272.0,"shares_display":"13,272","price_per_share":30.2,"price_display":"30.20","price_state":"stated","total_value":400814.4,"total_display":"400,814.40","total_whole":"400,814","shares_owned_after":1124974.0,"shares_owned_after_display":"1,124,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-13","scope":"insider"},{"id":4586950,"accession":"0001209191-21-055782","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-055782","line_url":"/filing/0001209191-21-055782","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43227.0,"shares_display":"43,227","price_per_share":30.510578342239803,"price_display":"30.51","price_state":"stated","total_value":1318880.77,"total_display":"1,318,880.77","total_whole":"1,318,881","shares_owned_after":1143417.0,"shares_owned_after_display":"1,143,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider","n_lines":2},{"id":4586940,"accession":"0001209191-21-055782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055782","line_url":"/filing/0001209191-21-055782#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14329.0,"shares_display":"14,329","price_per_share":30.31,"price_display":"30.31","price_state":"stated","total_value":434311.99,"total_display":"434,311.99","total_whole":"434,312","shares_owned_after":1181473.0,"shares_owned_after_display":"1,181,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-13","scope":"insider"},{"id":5336537,"accession":"0001209191-21-054604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-054604","line_url":"/filing/0001209191-21-054604#line-3","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5400.0,"shares_display":"5,400","price_per_share":30.15,"price_display":"30.15","price_state":"stated","total_value":162810.0,"total_display":"162,810.00","total_whole":"162,810","shares_owned_after":1195802.0,"shares_owned_after_display":"1,195,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-02","scope":"insider"},{"id":5336533,"accession":"0001209191-21-054604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054604","line_url":"/filing/0001209191-21-054604#line-2","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21986.0,"shares_display":"21,986","price_per_share":30.38,"price_display":"30.38","price_state":"stated","total_value":667934.68,"total_display":"667,934.68","total_whole":"667,935","shares_owned_after":1201202.0,"shares_owned_after_display":"1,201,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-02","scope":"insider"},{"id":5336528,"accession":"0001209191-21-054604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054604","line_url":"/filing/0001209191-21-054604#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19520.0,"shares_display":"19,520","price_per_share":30.12,"price_display":"30.12","price_state":"stated","total_value":587942.4,"total_display":"587,942.40","total_whole":"587,942","shares_owned_after":1223188.0,"shares_owned_after_display":"1,223,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-02","scope":"insider"},{"id":4103831,"accession":"0001209191-21-053964","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-053964","line_url":"/filing/0001209191-21-053964#line-5","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001776412","owner_name":"Schroeder Thilo","owner_display_name":"Schroeder Thilo","owner_url":"/insider/0001776412","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13233.0,"shares_display":"13,233","price_per_share":30.05,"price_display":"30.05","price_state":"stated","total_value":397651.65,"total_display":"397,651.65","total_whole":"397,652","shares_owned_after":1242708.0,"shares_owned_after_display":"1,242,708","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-08-30","scope":"insider"}],"collapsed":true,"next_cursor":"2021-08-30|4103831","ledger_fault":false,"count":{"value":135,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":38,"open_market":true},{"code":"S","label":"Open-market sale","n":97,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":135},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Director","n_filings":9,"first_seen":"2022-03-04","last_seen":"2024-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director","n_filings":27,"first_seen":"2021-03-26","last_seen":"2021-10-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"Silverback Therapeutics, Inc.","url":"/issuer/0001671858","role":"Director","n_filings":1,"first_seen":"2020-12-08","last_seen":"2020-12-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776412","retrieved_at":"2026-08-26T16:49:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}